Pittsburgh compound B as a marker of cognitive decline

ISSN： 1479-6708

Source： Future Neurology, Vol.5, Iss.4, 2010-07, pp. : 519-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers

By Knight William D.

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 293-300

Oxford University Press

Access to resources Recommend Favorite

Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology

Current Alzheimer Research, Vol. 12, Iss. 3, 2015-03 ,pp. : 278-286

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of brain amyloid β deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B

By Kawai Nobuyuki

Brain Injury, Vol. 27, Iss. 9, 2013-08 ,pp. : 1026-1031

Informa Healthcare

Access to resources Recommend Favorite

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimers disease

By Kadir Ahmadul

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 301-317

Oxford University Press

Access to resources Recommend Favorite

Metabolic Syndrome and Cognitive Decline

Current Alzheimer Research, Vol. 4, Iss. 2, 2007-04 ,pp. : 123-126

Bentham Science Publishers

Access to resources Recommend Favorite